 |
Imvax
Last updated: May 01, 2024
CEO John Furey
Country: USA | Funding: $189.7M (+)
Website: https://www.imvax.com/
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Website: https://www.imvax.com/
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
